New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Mitochondrial dysfunction and impaired energy metabolism are hallmarks of neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS.
• These deficits are observed both within the central nervous system and systemically.

Purpose of the Study:

• To review therapies impacting mitochondrial energy metabolism for neurodegenerative diseases.
• Focus on pre-clinical and clinical studies published up to May 2016.

Main Methods:

• Literature review of therapeutic interventions.
• Analysis of studies targeting mitochondrial function and energy pathways.

Main Results:

• Mitochondrial dysfunction is a key driver of neurodegenerative disease progression.
• Therapeutic initiatives targeting these pathways have yielded mixed results.

Conclusions:

• Current treatments for neurodegenerative diseases affecting mitochondrial energy metabolism have shown variable efficacy.
• Further investigation into the fundamental mechanisms of mitochondrial dysfunction and bioenergetic failure is crucial for developing effective therapies.